Artur Martynov,Boris S. Farber,Sonya Sophya Farber
申请号：
US12931464
公开号：
US20120195856A1
申请日:
2011.02.01
申请国别(地区):
US
年份:
2012
代理人:
摘要：
This invention may be used in human and veterinary medicine in combination with traditional methods of treatment of cardiovascular illnesses for the purpose of increasing their effectiveness.A method of treating patients with cardiovascular illnesses, distinct in that an anti-viral drug is used as an additional component of standard treatment before the beginning of and in parallel with standard treatment, in which Acyclovir, Valacyclovir, alpha interferon, a specific antiviral immunoglobulin or a combination of these substances are used as an anti-viral drug, which may be used for inclusion in the standard scheme of treatment of patients with cardiovascular diseases.The proposed method allows us to significantly improve the results of the treatment of patients with cardiovascular system pathology, decrease the number of relapses, improve patients quality of life, and significantly extend their lives. Because the proposed drugs are already approved for use, there are no technical difficulties facing their inclusion in the treatment plans of patients with cardiovascular system pathology.
